Zydus and Formycon strike an exclusive US-Canada deal for FYB206, a Keytruda biosimilar, with Formycon to file a BLA and Zydus entering North American biosimilars.Read More
Zydus Lifesciences (MRK) and Formycon in Keytruda biosimilar pact for US, Canada market
By Stock Titan
